Robert Lehr, MD
Dermatology · Oklahoma City, OKNPI 1619901634
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 542 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,754, 4.3 times the $635 reported in 2019.
Across 542 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- Pfizer$1K
- Lilly USA, LLC$1K
- Sun Pharmaceutical Industries Inc.$1K
- Regeneron Healthcare Solutions, Inc.$987
- Johnson & Johnson$887
- plus $4K from 22 others
What the payments were for
- Food & beverage$10,29596%
- Education$4594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 56 | $1,467 |
| Pfizer | 68 | $1,311 |
| Lilly USA, LLC | 64 | $1,182 |
| Sun Pharmaceutical Industries Inc. | 59 | $1,181 |
| Regeneron Healthcare Solutions, Inc. | 43 | $987 |
| Johnson & Johnson | 35 | $887 |
| Novartis | 48 | $823 |
| AbbVie | 48 | $687 |
| E.r. Squibb & Sons, L.L.C. | 22 | $419 |
| UCB, Inc. | 20 | $389 |
| Mayne Pharma Commercial LLC | 21 | $286 |
| Galderma Laboratories, L.p. | 18 | $189 |
| Incyte Corporation | 4 | $154 |
| Amgen | 8 | $145 |
| LEO Pharma Inc. | 7 | $119 |
| Genentech USA, Inc. | 5 | $104 |
| Boehringer Ingelheim | 4 | $86 |
| Zimvie Inc. | 1 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Almirall LLC | 1 | $29 |
| Dermavant Sciences, Inc. | 1 | $27 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Dermira, Inc. | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Merck | 1 | $13 |
| Organon | 1 | $9 |
How this compares
$10,754 in reported general payments places this provider in the 80th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 15 | $307,828 |
| Dupixent PenDupilumab | 59 | $247,902 |
| OdomzoSonidegib Phosphate | 12 | $188,851 |
| Dupixent SyringeDupilumab | 47 | $188,429 |
| Humira(Cf) PenAdalimumab | 14 | $94,978 |
| Taltz AutoinjectorIxekizumab | 12 | $81,329 |
| Fluorouracil | 128 | $9,038 |
| Clobetasol Propionate | 130 | $5,469 |
| Ketoconazole | 249 | $4,712 |
| Tacrolimus | 54 | $4,687 |
| ZenataneIsotretinoin | 22 | $4,613 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 265 | $4,265 |
| Dutasteride | 158 | $4,103 |
| Triamcinolone Acetonide | 463 | $3,639 |
| Acitretin | 12 | $3,491 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Courtney CookOklahoma City$10K
- Clifford HendersonOklahoma City$9K
- Roy RindlerOklahoma City$9K
- Emily ArchbaldOklahoma City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.